ArticleActa oncologica (Stockholm, Sweden)2016

Pak1, adjuvant tamoxifen therapy, and breast cancer recurrence risk in a Danish population-based study.

Thomas P Ahern et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.